SENDROW JERROLD purchased 99.9% of their position (4.50K shares) of VIRPAX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $5.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/26/2022ACC: 0001493152-22-015224
Director
Since Feb 2021
+4.50K
Net shares
Net buyer
$5.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.50K acquired
Non-Derivative Transactions1
Common Stock, $0.00001 par value
Direct
Shares
+4.50K
Price / share
$1.29
Trade value
$5.80K
% of position
99.9%
5/24/2022
4.51K→9.01K
Total
Net shares
+4.50K
Net value
$5.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.00001 par value Direct | 5/24/2022 | P · Purchase | +4.50K | $1.29 | $5.80K | 99.9% | 4.51K | 9.01K |
| Total | +4.50K | $5.80K | ||||||
Derivative Transactions0
No derivative transactions reported